Published in Int J Biol Macromol on February 01, 1992
Conformation of dehydropentapeptides containing four achiral amino acid residues - controlling the role of L-valine. Beilstein J Org Chem (2014) 0.80
Observation of glycine zipper and unanticipated occurrence of ambidextrous helices in the crystal structure of a chiral undecapeptide. BMC Struct Biol (2007) 0.75
Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br J Pharmacol (2000) 1.97
Control of peptide conformation by the Thorpe-Ingold effect (C alpha-tetrasubstitution). Biopolymers (2001) 1.64
Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice. Br J Pharmacol (2008) 1.46
Preventing abnormalities in signal transduction of T cells in cancer: the promise of cytokine gene therapy. Immunol Today (1996) 1.45
A new selective antagonist of the nociceptin receptor. Br J Pharmacol (1998) 1.41
Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide. J Med Chem (1997) 1.36
Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides. Mol Med (1995) 1.34
Presence and bronchomotor activity of protease-activated receptor-2 in guinea pig airways. Am J Respir Crit Care Med (2000) 1.24
Sensitive criteria for the critical size for helix formation in oligopeptides. Proc Natl Acad Sci U S A (1969) 1.24
Brain auditory activation measured by near-infrared spectroscopy (NIRS) in neonates. Pediatr Res (2001) 1.18
Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist. Br J Pharmacol (2000) 1.18
Long polypeptide 3(10)-helices at atomic resolution. Proc Natl Acad Sci U S A (1986) 1.18
Structure determination of racemic trichogin A IV using centrosymmetric crystals. Nat Struct Biol (1994) 1.17
Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. Br J Anaesth (2009) 1.15
Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endow delta antagonists to manifest mu agonism or mu antagonism. J Med Chem (1999) 1.11
High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: evidence for nosocomial transmission of HCV. Kidney Int (1995) 1.09
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies. Naunyn Schmiedebergs Arch Pharmacol (1999) 1.08
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. Br J Pharmacol (1998) 1.07
Studies of peptides forming 3(10)- and alpha-helices and beta-bend ribbon structures in organic solution and in model biomembranes by Fourier transform infrared spectroscopy. Biochemistry (1991) 1.05
Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity. J Med Chem (1997) 1.05
Peptaibol antibiotics: a study on the helical structure of the 2-9 sequence of emerimicins III and IV. Proc Natl Acad Sci U S A (1982) 1.03
Nociceptin/orphanin FQ receptor ligands. Peptides (2000) 1.02
Function of negative charge in the "address domain" of deltorphins. J Med Chem (1991) 1.02
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist. J Med Chem (1998) 1.02
Orientation and immersion depth of a helical lipopeptaibol in membranes using TOAC as an ESR probe. Biopolymers (1999) 1.01
The mouse vas deferens: a pharmacological preparation sensitive to nociceptin. Eur J Pharmacol (1996) 1.00
Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor. J Med Chem (2000) 1.00
Effect of the three-dimensional structure on the deamidation reaction of ribonuclease A. J Pept Res (1999) 0.98
Lipopeptaibols, a novel family of membrane active, antimicrobial peptides. Cell Mol Life Sci (2001) 0.97
Solid-phase synthesis of peptides containing the spin-labeled 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid (TOAC). J Pept Res (2001) 0.96
Prevalence of undiagnosed coeliac syndrome in osteoporotic women. J Intern Med (2001) 0.95
Interaction of deltorphin with opioid receptors: molecular determinants for affinity and selectivity. Peptides (1993) 0.95
Synthesis and conformational studies of peptides containing TOAC, a spin-labelled C alpha, alpha-disubstituted glycine. J Pept Sci (1997) 0.94
Intramolecularly hydrogen-bonded peptide conformations. CRC Crit Rev Biochem (1980) 0.94
Selective cleavage of the single tryptophanyl peptide bond in horse heart cytochrome c. FEBS Lett (1973) 0.94
Characterization of the locomotor activity-inhibiting effect of nociceptin/orphanin FQ in mice. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.94
Perspectives of protein kinase C (PKC) inhibitors as anti-cancer agents. Mini Rev Med Chem (2009) 0.94
Agonists at the δ-opioid receptor modify the binding of µ-receptor agonists to the µ-δ receptor hetero-oligomer. Br J Pharmacol (2010) 0.94
Selective opioid dipeptides. Biochem Biophys Res Commun (1994) 0.94
The secondary structure of a membrane-modifying peptide in a supramolecular assembly studied by PELDOR and CW-ESR spectroscopies. J Am Chem Soc (2001) 0.93
Crystallographic characterization of geometry and conformation of TOAC, a nitroxide spin-labelled C alpha,alpha-disubstituted glycine, in simple derivatives and model peptides. Int J Pept Protein Res (1996) 0.93
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test. Eur J Neurosci (2003) 0.92
Peptide models for beta-turns. A circular dichroism study. Int J Pept Protein Res (1984) 0.92
Solid-state infrared absorption spectra and chain arrangement in some synthetic homooligopeptides in the intermolecularly hydrogen-bonded pleated-sheet beta-conformation. Biopolymers (1977) 0.91
Mortality rate and outcome factors in mixed cryoglobulinaemia: the impact of hepatitis C virus. Scand J Rheumatol (2010) 0.91
Vacuum ultraviolet circular dichroism of beta-forming alkyl oligopeptides. J Am Chem Soc (1976) 0.91
In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist; correlations between desensitization and tolerance. Br J Pharmacol (2007) 0.91
What peptides these deltorphins be. Prog Neurobiol (1999) 0.91
Experimental pancreatic cancer in the rat treated by photodynamic therapy. Br J Surg (1994) 0.91
Determining the occurrence of a 3(10)-helix and an alpha-helix in two different segments of a lipopeptaibol antibiotic using TOAC, a nitroxide spin-labeled C(alpha)-tetrasubstituted alpha-aminoacid. Bioorg Med Chem (1999) 0.91
Structural requirements for formyl homooligopeptide chemoattractants. Biochemistry (1984) 0.90
Total body water estimation using bioelectrical impedance: a meta-analysis of the data available in the literature. Acta Diabetol (2003) 0.89
[Nphe(1)]nociceptin-(1-13)-NH(2) antagonizes nociceptin effects in the mouse colon. Eur J Pharmacol (1999) 0.89
Fullerene-based amino acids and peptides. J Pept Sci (2001) 0.88
Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.88
The nociceptin/orphanin FQ receptor antagonist, [Nphe1]NC(1-13)NH2, potentiates morphine analgesia. Neuroreport (2000) 0.88
[Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist. Br J Pharmacol (2013) 0.88
Dinuclear Zn(2+) complexes of synthetic heptapeptides as artificial nucleases. J Am Chem Soc (2001) 0.88
EXIT procedure in a twin gestation and review of the literature. Am J Perinatol (2001) 0.88
Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone. Bone (2006) 0.87
On the oxy analogues to the 4 leads to 1 intramolecularly hydrogen-bonded peptide conformations. Macromolecules (1976) 0.87
Electron spin resonance of TOAC labeled peptides: folding transitions and high frequency spectroscopy. Biopolymers (2000) 0.87
On the stereospecific reduction of the aldolase-fructose 1,6 bisphosphate complex by NaBH4. Biochem Biophys Res Commun (1977) 0.87
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives. Br J Pharmacol (2014) 0.87
Na+ mechanism of delta-opioid receptor induced protection from anoxic K+ leakage in the cortex. Cell Mol Life Sci (2009) 0.86
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family. Life Sci (2002) 0.86
Synthesis and pharmacological activity of dermorphin and its N-terminal sequences. Int J Pept Protein Res (1982) 0.86
Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.86
Structural versatility of peptides containing C alpha, alpha-dialkylated glycines. An X-ray diffraction study of six 1-aminocyclopropane-1-carboxylic acid rich peptides. Int J Biol Macromol (1989) 0.86
Solution and solid-state structure of the diketopiperazine of tyrosyl-tetrahydroisoquinoline-3-carboxylic acid. Int J Pept Protein Res (1995) 0.86
Pharmacological characterization of nociceptin receptor: an in vitro study. Can J Physiol Pharmacol (1997) 0.86
The antimicrobial peptide trichogin and its interaction with phospholipid membranes. Eur J Biochem (1999) 0.85
Location and aggregation of the spin-labeled peptide trichogin GA IV in a phospholipid membrane as revealed by pulsed EPR. Biophys J (2006) 0.85
Pycnodysostosis: review and case report. Minerva Stomatol (2014) 0.85
Structure/function relationships in the hemoglobin components from moray (Muraena helena). Eur J Biochem (1995) 0.85
Studies on the antinociceptive effect of [Nphe1]nociceptin(1-13)NH2 in mice. Neurosci Lett (2001) 0.84
Conformational studies of equilibrium structures in fragments of horse heart cytochrome c. Eur J Biochem (1975) 0.84
Post-transcriptional regulation of MHC class II expression in human T cells. Cell Immunol (1992) 0.84
A topographically and conformationally constrained, spin-labeled, alpha-amino acid: crystallographic characterization in peptides. J Pept Res (2005) 0.84
Conformational aspects of polypeptide structure. XXX. Rotatory properties of cyclic and bicyclic amides. Restricted and rigid model compounds for peptide chromophores. J Am Chem Soc (1969) 0.84
Breastfeeding and neonatal intensive care unit policies. Int J Epidemiol (1997) 0.83
Parallel bioassay of 39 tachykinins on 11 smooth muscle preparations. Structure and receptor selectivity/affinity relationship. Peptides (2000) 0.83
Conformational analysis of protected norvaline oligopeptides by high resolution proton magnetic resonance. J Am Chem Soc (1977) 0.83
Crystallographic characterization of conformation of 1-aminocyclopropane-1-carboxylic acid residue (Ac3c) in simple derivatives and peptides. Int J Pept Protein Res (1989) 0.83
B chromosomes in Crustacea Decapoda. Cytogenet Genome Res (2004) 0.82
Membrane thickness and the mechanism of action of the short peptaibol trichogin GA IV. Biochim Biophys Acta (2012) 0.82
Stereospecificity of amino acid side chains in deltorphin defines binding to opioid receptors. J Med Chem (1992) 0.82
Chain-length dependence for secondary structure formation of homo-oligopeptides from epsilon-tert.-butyloxycarbonyl-L-lysine with a lipophilic C-terminal group. Int J Pept Protein Res (1984) 0.82